| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |